Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
2019 · The Lancet Neurology · 2,430 citations
https://doi.org/10.1016/s1474-4422(19)30320-5
F
Francesc Valldeoriola
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
300
Papers
19.8K
Citations
73
h-index
201
i10-index
Francesc Valldeoriola is an academic researcher from Hospital Clínic de Barcelona. The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Neurological disorders and treatments & Botulinum Toxin and Related Neurological Disorders. The author has an h-index of 73, co-authored 255 publications.
ORCID: 0000-0002-8680-4274Papers by this author
worksLevodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
2017 · Parkinsonism & Related Disorders · 206 citations
https://doi.org/10.1016/j.parkreldis.2017.09.018
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
2019 · npj Parkinson s Disease · 158 citations
https://doi.org/10.1038/s41531-019-0080-x
Identification of sixteen novel candidate genes for late onset Parkinson’s disease
2021 · Molecular Neurodegeneration · 83 citations
https://doi.org/10.1186/s13024-021-00455-2
The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease
2013 · Journal of Neurology · 80 citations
https://doi.org/10.1007/s00415-013-7148-z
Dementia and severity of parkinsonism determines the handicap of patients in late‐stage Parkinson's disease: the Barcelona−Lisbon cohort
2014 · European Journal of Neurology · 43 citations
https://doi.org/10.1111/ene.12567
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat